|
市場調査レポート
商品コード
1261512
光学イメージングの世界市場規模、シェア、産業動向分析レポート製品別、エンドユーザー別、技術別、用途別、治療領域別、地域別展望と予測、2022年~2028年Global Optical Imaging Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Technique, By Application, By Therapeutic Area, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
光学イメージングの世界市場規模、シェア、産業動向分析レポート製品別、エンドユーザー別、技術別、用途別、治療領域別、地域別展望と予測、2022年~2028年 |
出版日: 2023年03月31日
発行: KBV Research
ページ情報: 英文 338 Pages
納期: 即納可能
|
光学イメージング市場規模は、2028年には31億米ドルに達し、予測期間中に13.1%のCAGRで市場成長すると予測されています。
例えば、ラマン分光法は光の非弾性散乱を調べますが、蛍光や燐光は吸収後の発光に依存します。光イメージングでは、ナノメートル(nm)の範囲で非常に高い空間分解能が得られ、リアルタイムかつ定量的なデータが得られる可能性があります。また、組織を照明し、体内深部から発光を集めることができる光ファイバー内視鏡プローブが、この問題を解決する一助となる可能性があります。また、軟部組織は可視光線よりも近赤外光線の方が散乱や吸収が少ないため、近赤外光イメージングを利用すれば数cmの深さまで観察することができます。
蛍光画像は、先進的な蛍光媒介トモグラフィ/マイクロCTのようなハイブリッドトモグラフィシステムに使用され、医薬品研究において従来のPET分析に代わる有用な選択肢を提供します。食道病変や大腸腺腫の早期発見を促進するために、広視野NIR蛍光分子内視鏡やその他のデバイス設計が推進されています。
COVID-19インパクト分析
COVID-19の大流行により、医師をはじめとするヘルスケア従事者は社会的距離を保つことがより重要になりました。COVID-19の影響で、いくつかの画像診断部門において、光イメージング症例数が急速に減少しています。光イメージング症例の減少は、すべての診療環境の短期的および長期的な経済的安定性に深刻な影響を与えます。COVID-19のために、光イメージング装置のニーズが世界的に大きく減少しています。光イメージング装置の需要の大幅な減少は、パンデミックによる各国の選択手術のキャンセルや病院・診断施設の閉鎖が主な原因です。また、外来患者数の減少は、予測期間を通じて市場の拡大を抑制すると予想されます。
市場成長要因
技術進歩
眼球強膜のコラーゲン線維の組織変化を特定できる最先端の光学イメージング法が、政府からの資金提供を受けて生物医学エンジニアによって開発されています。この技術は、強膜タンパク質の特定の変化と早期発症の緑内障を関連付けるコンピューターモデルを使用しています。この新しい検査により、視力を維持するための早期治療と、継続的な非侵襲的治療反応モニタリングが可能になります。エンジニアは、脳の血流や酸素使用などの代謝過程を検出する重要なリアルタイムイメージングのための光学イメージングデバイスを開発しています。これが地域市場の成長を支えています。
適用範囲の拡大
可視光、近赤外光、近紫外光のラマン散乱は、ラマン分光法の基礎となるものです。物質の分子振動がレーザー光と相互作用してエネルギー変化を起こし、物質の化学組成を明らかにします。化合物の同定、結晶や物質の構造解析などに利用されています。ラマンガスアナライザーは、外科手術で麻酔ガスの混合状態をモニターするために使用されています。様々な病気の診断や治療に光学イメージング技術が広く使われていることが、光学イメージング市場の成長を後押しすると期待されています。
市場の抑制要因
ヘルスケア従事者の不足
保健医療従事者は、保健医療システムの運営に不可欠な存在です。その利用可能性、アクセス性、受容性、質は、ヘルスケアの適用範囲を拡大し、可能な限り最大の健康レベルを享受する権利を達成するためのすべての決定要因です。WHOは、2030年までに、低・中所得国を中心に1,000万人の医療従事者が不足すると予測しています。あらゆる社会経済レベルの政府が、程度の差こそあれ、労働力の訓練、雇用、配置、維持、業績について課題を抱えています。これらの要素は、この地域における市場の拡大を後押ししています。
製品概要
製品に基づき、光学イメージング市場は、イメージングシステム、カメラ、ソフトウェア、照明システム、レンズ&その他に区分されます。イメージングシステムセグメントは、2021年に最大収益シェアで光学イメージング市場を独占しました。これは、がん、眼科、その他の分野で幅広く使用されていることによる。これらのシステムは、数ミリまでの撮像深度で、リアルタイムでミクロンレベルの解像度、1D深度、2D断面、3D体積の画像を提供し、有害な放射線がないため、頻繁に使用されています。
アプリケーションの展望
アプリケーションに基づいて、光学イメージング市場は病理イメージングと術中イメージングに分けられます。術中イメージングセグメントは、2021年の光学イメージング市場でかなりの収益シェアを獲得しました。これは、術中イメージングとモニタリングにより、医師が手術の指針となる生理学的情報にアクセスでき、長期的には回復時間や生活の質を高めることができるためです。このような状況において、光学画像は、非常に実用的で、携帯可能で、手頃な価格で、関心のあるいくつかの生理学的要因に感応するリアルタイムのソリューションを提供します。
エンドユーザーの展望
エンドユーザー別では、光学イメージング市場は、病院&クリニック、研究所、製薬&バイオテクノロジー企業に分類されます。研究室セグメントは、2021年に光学イメージング市場で突出した収益シェアを記録しました。これは、光イメージングのさまざまな新しいアプリケーションを生み出すために、研究開発業務に重点を置くようになったためです。前臨床研究や創薬手順でより多くの光学イメージング技術が使用されるようになり、市場は発展すると予想されます。ライフサイエンス業界における研究開発活動の活発化は、予測期間におけるこのセグメントの拡大をさらに後押しするでしょう。
治療領域の展望
治療分野に基づき、光イメージング市場は、眼科、腫瘍学、心臓学、皮膚科学、神経学、その他に二分されます。オンコロジーセグメントは、2021年に光学イメージング市場で最も高い収益シェアを記録しました。これは、光学的な方法で組織を検査することで、組織の生化学的側面と構造的側面の両方を検出できるためです。また、高感度、低コスト、高解像度という利点もあります。また、この技術は、がんの早期発見を助け、非侵襲的であることから、人気を集めています。がんがより一般的になりつつある中、がんの早期発見に役立つ光イメージングにより、このセグメントの成長は急上昇するでしょう。
技術的展望
技術に基づいて、光イメージング市場は、光コヒーレンストモグラフィー、近赤外分光法、ハイパースペクトルイメージング、光音響トモグラフィーに分けられます。2021年の光イメージング市場では、光音響トモグラフィーの分野が顕著な成長率を獲得しました。これは、光音響トモグラフィが分子イメージングと機能的イメージングの両方に対応するハイブリッドな非侵襲的イメージング技術であるためです。また、非侵襲的な技術への需要が高まっており、光トモグラフィは従来の光イメージング競合製品よりもバイオメディカルイメージングにおいて優れた性能を発揮します。これらすべての理由が、予測期間中の同分野の拡大に寄与すると予想されます。
地域別展望
地域別に、光イメージング市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米地域は、2021年に光学イメージング市場で最も高い収益シェアを獲得しました。これは、有能な人材の確保、強力な研究インフラ、投資や資金を提供することでこの分野の技術向上を支援する政府の試みによるものです。さらに、この分野で技術的に改善されたアイテムの迅速な採用は、市場の拡大をさらに加速させると予想されます。
市場参入企業がとる主な戦略は、買収です。カーディナルマトリックスで提示された分析によると、Abbott LaboratoriesとLeica Microsystems GmbH(Danaher Corporation)が光学イメージング市場の先行者です。カールツァイスAGやキヤノン株式会社(キヤノンメディカルシステムズ株式会社)などの企業は、オプティカルイメージング市場における主要な革新者の一人です。
List of Figures
The Global Optical Imaging Market size is expected to reach $3.1 billion by 2028, rising at a market growth of 13.1% CAGR during the forecast period.
Optical imaging technologies have great potential for the healthcare sector in terms of improving illness detection, prevention, and treatment. Due to factors such as emerging application areas, increased consumer demand for noninvasive technologies, and an increase in chronic diseases and eye conditions, the market for optical imaging systems is growing. Due to the growing emphasis on early illness diagnosis and the desire for efficient solutions, optical imaging system sales are anticipated to rise quickly.
The science of optical imaging, which employs light to examine cellular and molecular activity in live organisms, is non-invasive and non-ionizing. Electromagnetic radiation, including visible light, contains wave and particle characteristics. Depending on the makeup of the tissue, photons may be absorbed, reflected, or dispersed as they pass through it. Various optical imaging techniques examine these interactions to produce distinctive spectral fingerprints that might provide information about the molecular structure of the target tissue.
For instance, Raman spectroscopy examines the inelastic scattering of light, whereas fluorescence and phosphorescence rely on the emission of light after its absorption. Optical imaging offers a very high spatial resolution in the nanometre (nm) range and may give real-time and quantitative data. Fiberoptic endoscopic probes, which enable tissue lighting and collecting the emitted light from deep inside the body, may partially help overcome this. Moreover, soft tissues exhibit less scattering and absorption in the electromagnetic spectrum's near-infrared (NIR) region than in the visible band, allowing the probing depth to be raised to a few centimeters when utilizing NIR optical imaging.
Fluorescence imaging is used in hybrid tomographic systems like advanced fluorescence-mediated tomography/micro-CT, which provides a useful alternative to traditional PET analysis in drug research. Wide-field NIR fluorescence molecular endoscopy and other device designs have been promoted for enhancing the early detection of esophageal lesions and colorectal adenomas.
COVID-19 Impact Analysis
The COVID-19 pandemic made it more important for physicians and other healthcare workers to maintain social distancing. Due to COVID-19, optical imaging case volumes have rapidly decreased in several imaging and diagnostic departments. The fall in optical imaging cases seriously impacts the short- and long-term economic stability of all practice settings. The need for optical imaging devices has significantly decreased globally because of COVID-19. The large drop in demand for optical imaging equipment is primarily attributable to canceling of elective operations and the closing of hospitals and diagnostic facilities in various nations due to the pandemic. Also, the decline in outpatient visits is anticipated to restrain market expansion throughout the projection period.
Market Growth Factors
Technological progress
A cutting-edge optical imaging method that can identify changes in the organization of the collagen fibers in the eye sclera is being developed by biomedical engineers with funding from the government. The technique uses a computer model that links certain alterations in sclera proteins to early-onset glaucoma. The new test will allow for early treatment that preserves eyesight and ongoing non-invasive treatment response monitoring. Engineers are developing an optical imaging device for crucial real-time imaging that detects brain blood flow and metabolic processes, including oxygen use. This supports the growth of the regional market.
Expanding the spheres of applicability
Raman scattering of visible, near-infrared, or near-ultraviolet light provides the basis for Raman spectroscopy. The material's molecular vibrations interact with the laser light, causing energy changes that disclose the substance's chemical composition. Uses include the identification of chemical compounds and the crystal and material structure. Raman gas analyzers are used in surgery to monitor the anesthetic gas mixture. The wide usage of optical imaging techniques for diagnosing and treating various diseases is expected to boost the optical imaging market growth.
Market Restraining Factors
Lack of healthcare workers
Health workers are essential to the operation of health systems. Their availability, accessibility, acceptability, and quality are all determinants of expanding healthcare coverage and attaining the right to the enjoyment of the greatest possible level of health. By 2030, the WHO predicts a ten-million-person shortage in the health workforce, mostly in low- and lower-middle-income nations. To varied degrees, governments at all socioeconomic levels have challenges with their workforce's training, employment, deployment, retention, and performance. These elements are assisting the market's expansion in the region.
Product Outlook
Based on product, the optical imaging market is segmented into imaging systems, camera, software, illuminating systems and lenses & others. The imaging systems segment dominated the optical imaging market with maximum revenue share in in 2021. This is due to its extensive use in cancer, ophthalmology, and other fields. These systems are frequently used because they provide real-time, micron-level resolution, 1D depth, 2D cross-sectional, and 3D volumetric pictures at imaging depths of up to a few millimeters and no harmful radiation.
Application Outlook
On the basis of application, the optical imaging market is divided into pathological imaging and intraoperative imaging. The intraoperative imaging segment garnered a substantial revenue share in the optical imaging market in 2021. This is owing to intraoperative imaging and monitoring, which gives doctors access to physiological information that may be used to guide surgery and enhance recovery time and quality of life in the long run. Optical imaging in this context provides extremely practical, portable, affordable, and real-time solutions sensitive to several physiological factors of interest.
End User Outlook
By end user, the optical imaging market is classified into hospitals & clinics, research laboratories and pharmaceutical & biotechnology companies. The research laboratories segment recorded a prominent revenue share in the optical imaging market in 2021. This is due to the increased emphasis on R&D operations to create different new applications of optical imaging. The market is expected to develop as more optical imaging techniques are used in preclinical research and drug discovery procedures. The increasing R&D efforts in the life sciences industry will further boost the segment's expansion in the forecasted period.
Therapeutic Area Outlook
Based on the therapeutic area, the optical imaging market is bifurcated into ophthalmology, oncology, cardiology, dermatology, neurology and others. The oncology segment registered the highest revenue share in the optical imaging market in 2021. This is because the optical way of examining tissues can detect both the biochemical and structural aspects of the tissue. It also has the benefits of high sensitivity, low cost, and high resolution. The technique is also gaining popularity since it aids in the early identification of cancer and is non-invasive. As cancer is becoming more common, along with the benefits optical imaging provides in early cancer detection, the segment's growth will surge.
Technique Outlook
On the basis of technique, the optical imaging market is divided into optical coherence tomography, near infrared spectroscopy, hyperspectral imaging and photoacoustic tomography. The photoacoustic tomography segment garnered a remarkable growth rate in the optical imaging market in 2021. This is because photoacoustic tomography is a hybrid noninvasive imaging technique for both molecular and functional imaging. In addition, the demand for noninvasive technology is growing, and optical tomography performs better in biomedical imaging than its traditional optical imaging competitors. All these reasons are anticipated to contribute to the segment's expansion in the projected period.
Regional Outlook
Region-wise, the optical imaging market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the optical imaging market in 2021. This is due to the availability of qualified people, a strong research infrastructure, and government attempts to support technical improvement in the sector by providing investments and money. Moreover, quicker adoption of technologically improved items in the area is anticipated to accelerate market expansion further.
The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Abbott Laboratories and Leica Microsystems GmbH (Danaher Corporation) are the forerunners in the Optical Imaging Market. Companies such as Carl Zeiss AG and Canon, Inc. (Canon Medical Systems Corporation) are some of the key innovators in Optical Imaging Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss AG, Leica Microsystems GmbH (Danaher Corporation), Abbott Laboratories, Canon, Inc. (Canon Medical Systems Corporation), PerkinElmer, Inc., Topcon Corporation, Hamamatsu Photonics K.K., Koninklijke Philips N.V., Heidelberg Engineering, Inc. and Visionix Ltd.
Recent Strategies Deployed in Optical Imaging Market
Partnerships, Collaborations and Agreements:
Jan-2023: Canon came into partnership with ScImage, Inc., a Cloud-native image management company offering services to the healthcare industry. This partnership would enable Canon to leverage Sclmage cloud-driven image management and PACS solutions in enhancing Canon's outreach in hemodynamics empowering it to better serve its customers.
May-2022: Visionix partnered with Right MFG. Co., Ltd., an innovative medical devices manufacturer, for making growth in their businesses. With this partnership, Right MFG's expertise in offering advanced medical devices would enable Visionix to develop and deliver a product range for eyecare businesses facilitating eye care professionals.
Mar-2022: Hamamatsu Photonics K.K announced its collaboration with Proscia, a digital and computational pathology solutions provider, to enhance digital pathology embracement. Through this partnership, Hamamatsu's NanoZoomer® series of whole slide scanners for digital transformation would be combined with Proscia's Concentriq® platform to create an open ecosystem for raising the digital pathology embracement ratio in the market.
Aug-2020: Canon signed a partnership with Zebra Medical Vision, a computer vision startup serving healthcare, to broaden its AI offerings. With this partnership, Zebra Medical Vision's services into the Modality domain would empower Canon to deliver its AI1™ automated imaging analysis solutions to facilitate U.S. clinicians in the delivery of faster, and required diagnoses to patients.
Product Launches and Product Expansions:
Nov-2021: Koninklijke Philips N.V. unveiled AI-based MR suite of smart diagnostic systems. The MR portfolio would incorporate smart integrated solutions such as MR 7700 3.0T system, developed to accelerate MR examination, smooth workflow, improved diagnostic quality, and provide aid in the optimization of radiology operations.
Jul-2021: Canon announced the launch of Xephilio OCT-S1, an advanced Wide -field Swept Source Optical Coherence Tomography. Xephilio OCT-S1 would enable customers to capture high-resolution pictures of up to 23 x 20 mm in just one-time scanning. Additionally, it would allow users to use its wide-angle OCT Imaging Angiography feature and delivers OCTA images with enhanced visibility.
Apr-2021: Abbott unveiled an AI-powered coronary OCT imaging system in Europe. The AI-powered coronary OCT imaging system, developed by integrating imaging technology with AI and would offer surgeons an automated system useful in cardiac procedures, providing information quickly in the course of the placement of coronary stents.
Acquisitions and Mergers:
Jan-2023: Carl Zeiss completed the acquisition of Lenso, an optical 3D metrology manufacturer, to make developments in Zeiss's Industrial Quality and Research division. Through this acquisition, Carl Zeiss's industrial quality solutions would be utilized for Zeiss's Industrial Quality & Research division expansion across Poland.
Oct-2022: Carl Zeiss acquired GOM Metrology, to serve the UK customer base by providing better tactile and optical technology suite offerings. With this acquisition, GOM Metrology would bring its GOM software, machines, automated 3D coordinate computing technology, and 3D testing to strengthen Zeiss Industrial Quality Solutions' portfolio.
Oct-2021: Carl Zeiss took over Capture 3D, a 3D Scanning technology, photogrammetry, and automated inspection solutions provider, to make advancements in optical digitization systems. Through this acquisition, Capture 3D's capabilities in supplying required data intelligence for better decision-making would enable Zeiss to better support its customers by providing them the advanced measurement solutions.
Oct-2021: Canon acquired Redlen Technologies, developer and manufacturer of high-resolution CZT semiconductor detectors. Through this acquisition, Canon would make developments in its medical systems business by getting advanced radiation detection and imaging technology, utilized in CZT semiconductor detector modules, through Redlen Technologies to develop advanced PCCT systems.
Jul-2021: Topcon Corporation completed the acquisition of VISIA Imaging S.r.l, an Italian-based ophthalmic device manufacturing company. Through this acquisition, VISIA's expertise in manufacturing anterior segment evaluation hardware and software would be leveraged by Topcon to intensify Topcon's manufacturing and innovation capabilities in anterior segment devices and software that would advance Topcon's fundus imaging devices suite.
Market Segments covered in the Report:
By Product
By End User
By Technique
By Application
By Therapeutic Area
By Geography
Companies Profiled
Unique Offerings from KBV Research